Semi-annual Report for 2026
Filed with SSE · · 185 pages · Chinese
Jianmin Pharmaceutical Group Co Ltd. on 6ix
Earlier from Jianmin Pharmaceutical
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Inclusion of the Company's Products in the "National Essential Medicines List"
- Announcement on Attending the 2026 Collective Reception Day for Investors of Listed Companies in Hubei Jurisdiction
- Announcement on Obtaining Notice of Approval for Drug Clinical Trials
- Announcement on Implementation of Dividend Distribution for 2025
Later from Jianmin Pharmaceutical
- Announcement on Approval for Marketing of Crisaborole Ointment
- (600976)"Jianmin Pharmaceutical Group Co., Ltd."Announcement on Convening the Q3 2026 Performance Briefing
- (600976)"Jianmin Pharmaceutical Group Co., Ltd."Report for Q3 2026
Follow Jianmin Pharmaceutical into a list and get an email when it puts out news.
Follow Jianmin Pharmaceutical